1. Commissioned report › Research › Not peer-reviewed
2. Published

   A pilot clinical trial looking at the effect on lung cancer diagnosis of giving a chest X-Ray to smokers aged over 60 with chest symptoms: National Awareness and Early Diagnosis Initiative (NAEDI) Research Call Funding Partners Report

   Neal, R., Edwards, R., Yeo, S. T., Hurt, C. & The ELCID Team, Aug 2015

   Research output: Book/Report › Commissioned report

3. Published

   A review of economic models for second-line chemotherapy in the management of advanced, metastatic breast cancer.

   Hughes, D. & Hughes, D. A., 1 Jan 2001, 2001 ed. Unknown.

   Research output: Book/Report › Commissioned report

4. Published

   A study of the effects of the Carers Strategy in Wales on the needs of carers and the services they receive

   Seddon, D., Robinson, C. A., Russell, I. T., Woods, R. T., Tommis, Y., Reeves, C., Perry, J. K. & Boyle, M., 1 Jan 2007, 2007 ed. Unknown.

   Research output: Book/Report › Commissioned report

5. Published

   AWMSG criteria for appraising new medicines.

   Hughes, D. & Hughes, D. A., 1 Jan 2007, 2007 ed. Unknown.

   Research output: Book/Report › Commissioned report

6. Published

   All Wales Medicines Strategy Group Final Appraisal Report - Abacavir 600mg/lamivudine 300mg (Kivexa) in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus infection in adults and adolescents from 12 years of age.

   Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

   Research output: Book/Report › Commissioned report

7. Published

   All Wales Medicines Strategy Group Final Appraisal Report - Alemtuzumab (MabCampath) for the treatment of patients with B-cell chronic lymphocytic leukaemia for whom fludarabine combination chemotherapy is not appropriate.

   Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

   Research output: Book/Report › Commissioned report

8. Published

   All Wales Medicines Strategy Group Final Appraisal Report - Ambrisentan (Volibris) for pulmonary arterial hypertension.

   Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2009, 2009 ed. Unknown.

   Research output: Book/Report › Commissioned report

9. Published

   All Wales Medicines Strategy Group Final Appraisal Report - Anidulafungin (Ecalta) for the treatment of invasive candidiasis in adult non-neutropenic patients.

   Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2009, 2009 ed. Unknown.

   Research output: Book/Report › Commissioned report

10. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Atazanavir (Reyataz) in treatment-experienced patients.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

11. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Atazanavir (Reyataz) in treatment-naïve patients.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report